Back to Research

Organization profile

Axenoll Life Sciences

Axenoll Life Sciences is a technology company that utilizes patented 3D screen printing to manufacture high-resolution medical and life science products. The organization enables the industrial-scale production of bioprinted scaffolds, microfluidic chips, and advanced wound dressings through a gentle, low-temperature additive manufacturing process.43

Zurich, SwitzerlandFounded 2014

Overview

1. Executive Summary (Confidence: High)

Axenoll Life Sciences AG is a pioneer in the industrialization of "3D Mass Customization®".[44] Based in Zurich, Switzerland, with a high-tech manufacturing site in Jena, Germany, the company holds the global license for a unique 3D screen printing technology.[44] Unlike conventional bioprinting, which is often slow and unsuitable for mass production, Axenoll’s process allows for the rapid, parallel processing of thousands of items with sub-20 µm resolution.[44] This "gentle" technology is specifically designed to handle sensitive biological materials, including living cells and peptides, making it an ideal partner for the MedTech, cosmetics, and pharmaceutical industries.[43] Backed by an $8.26 million venture capital round, Axenoll serves as a comprehensive OEM partner, managing product development from initial idea to GMP-compliant serial production.[43]

This is an extract of the full organization profile. To access the full company profile, .

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.